ReviewCommunications medicine2024
Improving treatment of people with gastro-esophageal reflux disease refractory to proton pump inhibitors.
Joachim Labenz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it